Results 1 to 10 of about 24,869 (260)

Nevus sebaceus with syringocystadenoma papilliferum, prurigo nodularis, apocrine cystadenoma, basaloid follicular proliferation, and sebaceoma: case report and review of nevus sebaceus-associated conditions [PDF]

open access: gold, 2020
Nevus sebaceus is a benign skin hamartoma of congenital onset that grows during puberty, and in adulthood can develop secondary benign and malignant neoplasms.
Pallavi Basu   +3 more
openalex   +4 more sources

Orbital apocrine hidrocystoma with ptosis

open access: goldAmerican Journal of Ophthalmology Case Reports, 2022
Purpose: To describe a patient with orbital apocrine hidrocystoma presenting with ptosis and subsequent management. Observations: A 43-year-old woman presented to the oculoplastic surgery clinic with a left-sided ptosis and enlarging but painless mass in
Vincent Huang   +2 more
doaj   +2 more sources

Apocrine-eccrine carcinomas: molecular and immunohistochemical analyses. [PDF]

open access: yesPLoS ONE, 2012
Apocrine-eccrine carcinomas are rare and associated with poor prognosis. Currently there is no uniform treatment guideline. Chemotherapeutic drugs that selectively target cancer-promoting pathways may complement conventional therapeutic approaches ...
Long P Le   +10 more
doaj   +4 more sources

Syringocystadenoma PapilliferumA Case Series [PDF]

open access: yesNational Journal of Laboratory Medicine, 2022
Syringocystadenoma papilliferum is also known as papillary syringadenoma. This is a warty tumour of the scalp, neck and face that occurs at any age. These lesions usually have an adjacent nevus sebaceous or adjacent basal cell carcinoma.
Sushmitha Malpe Gopal   +2 more
doaj   +1 more source

The histologic spectrum of apocrine lesions of the breast [PDF]

open access: yesArchive of Oncology, 2004
New data on apocrine carcinoma of the breast, especially on its unusual pathogenesis, are the facts that justify this study. The aim of this study was to describe the morphological features in both benign apocrine lesions and invasive apocrine carcinomas
Trenkić Srbobran   +5 more
doaj   +1 more source

A varied presentation of dermal adnexal tumours: An institutional study

open access: yesAdvances in Human Biology, 2022
Introduction: Adnexal skin tumours are a heterogeneous group of uncommon tumours usually misdiagnosed clinically due to a huge variety of types and their variants. Histopathology usually helps in establishing the diagnosis.
Snigdha Sinha   +2 more
doaj   +1 more source

Apocrine carcinoma of the breast: Review

open access: yesForum of Clinical Oncology, 2023
Apocrine carcinoma of the breast is a rare subtype of breast carcinoma, which only presents as 4% among patients with breast cancer. The percentage varies based on the diagnostic criteria used by each institution to classify apocrine carcinoma.
Yang Chieh, Wang Irene, Yen Yun
doaj   +1 more source

A Morphologic Study of Cutaneous Adnexal Tumours [PDF]

open access: yesNational Journal of Laboratory Medicine, 2016
Introduction: Cutaneous adnexal tumour is a collective term for tumours arising from various adnexal units of the skin. These tumours share many common features even though they differentiate along one line.
Ramya Gandhi, Sowmya Srinivasan
doaj   +1 more source

FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast. [PDF]

open access: yesPLoS ONE, 2014
Apocrine carcinoma of the breast is a distinctive malignancy with unique morphological and molecular features, generally characterized by being negative for estrogen and progesterone receptors, and thus not electable for endocrine therapy.
Pavel Gromov   +7 more
doaj   +1 more source

Gross Cystic Disease Fluid Protein-15 (GCDFP-15) Expression Characterizes Breast Mucinous Carcinomas in Older Women

open access: yesDiagnostics, 2022
The predominant histological subtype of breast mucinous carcinoma in older women is type B (hypercellular type), and, in younger women, it is type A (hypocellular type).
Mayumi Kinoshita   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy